Citations

Showing 10 of 108104 citations.

Prospective Registry of Multiplex Testing (PROMPT): Feasible and sustainable.
Symecko, Heather , Brower, Jamie , Drogan, Christine , Harstad, Tricia, Pradhan, Nisha , Walsh, Michael F. , Offit, Kenneth , Salo‐Mullen, Erin E. , Hamilton, Jada G. , Balmañà, Judith , Couch, Fergus J. , Garber, Judy E. , Domchek, Susan M. , Robson, Mark E.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 1543-1543

10.1200/jco.2018.36.15_suppl.1543 Get It

Clinical evaluation of germline polymorphisms (SNPs) associated with disease response to capecitabine in metastatic breast cancer (MBC) (TBCRC 015).
Evans, Patrick , Morrow, Phuong K. , Storniolo, Anna Maria , Forero‐Torres, Andres , Poznak, Catherine Van , Merkel, Douglas E., Dees, Elizabeth Claire , Hahn, Olwen, Hoffman, Philip C., Nanda, Rita , O’Donnell, Peter H. , Choudhury, Noura J. , Ingle, James N. , Mayer, Ingrid A. , Fleming, Gini F. , Olopade, Olufunmilayo I. , Cox, Nancy J.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 1071-1071

10.1200/jco.2018.36.15_suppl.1071 Get It

Impact of abemaciclib on the time to subsequent chemotherapy and the time to second disease progression across the MONARCH 2 and 3 studies.
Tolaney, Sara M. , Campone, Mario , Barriga, Susana , Leo, Angelo Di , Llombart‐Cussac, Antonio , Dickler, Maura N. , Iwata, Hiroji , Toi, Masakazu , Kaufman, Peter A. , André, Valérie , Goetz, Matthew P. , Sledge, George W.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 1048-1048

10.1200/jco.2018.36.15_suppl.1048 Get It

Change in 21-gene recurrence score (RS) (Oncotype DX) after exposure to neoadjuvant endocrine therapy.
Mi, Lanyu , Anderson, Karen S. , Pockaj, Barbara A. , Gray, Richard J. , Dixon, Leslie E, Martinez, Erika D., Singh, Charanjit , Northfelt, Donald W. , Hilal, Talal

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e12650-e12650

10.1200/jco.2018.36.15_suppl.e12650 Get It

TOPACIO/Keynote-162: Niraparib + pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial.
Vinayak, Shaveta , Tolaney, Sara M. , Mita, Monica , McCann, Georgia A., Tan, Antoinette R. , Hendrickson, Andrea E. Wahner , Forero‐Torres, Andres , Zarwan, Corrine, Erban, John K. , Dezube, Bruce J., Zhou, Yinghui , Buerstatte, Nathan, Arora, Sujata, Achour, Haroun, Telli, Melinda L. , Schwartzberg, Lee Steven , Anders, Carey K. , Wulf, Gerburg M. , Dillon, Patrick Michael , Lynce, Filipa , Telli, Melinda L

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 1011-1011

10.1200/jco.2018.36.15_suppl.1011 Get It

Efficacy of primary prophylactic GCSF in patients receiving docetaxel based chemotherapy for breast cancer.
Zekri, Jamal , Nawaz, Azhar , Rasool, Haleem J. , Rahman, Hossam Abdel, Allithy, Ahmed, Abdelghany, Ehab Mosaad, Farag, Kamel, Ibrahim, Refaei Belal, Deibas, Mohamed Youssef, Kamel, Mohamed Kamal, Ahmad, Imran Nazir , Kamel, Mohamed Kamal, Dada, Reyad

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e12516-e12516

10.1200/jco.2018.36.15_suppl.e12516 Get It

CA15-3/MUC1 in CCTG MA-32 (NCT01101438): A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer (BC).
Parulekar, Wendy R. , Shepherd, Lois E. , Virk, Shakeel , Ennis, Marguerite , Mao, Fangya , Ligibel, Jennifer A. , Rastogi, Priya , Hobday, Timothy J. , Thompson, Alastair M. , Rabaglio, Manuela , Whelan, Timothy J. , Ennis, Marguerite , Rabaglio-Poretti, Manuela , Dowling, Ryan J.O. , Gelmon, Karen A. , Hershman, Dawn L. , Mayer, Ingrid A. , Lemieux, Julie , Stambolic, Vuk , Chen, Bingshu E. , Goodwin, Pamela J. , Whelan, Timothy J

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 557-557

10.1200/jco.2018.36.15_suppl.557 Get It

Breast cancer cell-free DNA (cfDNA) profiles reflect underlying tumor biology: The Circulating Cell-Free Genome Atlas (CCGA) study.
Liu, Minetta C. , Maddala, Tara, Aravanis, Alex, Beausang, John F., Filippova, Darya , Gross, Samuel, Jamshidi, Arash , Shen, Ling , Valouev, Anton, Venn, Oliver, Smith, David A. , Curtis, Christina , Williams, Richard T. , Hartman, Anne‐Renee , Baselga, José, Aravanis, Alexander M. , Hubbell, Earl , Gross, Samuel, Kurtzman, Kathryn N. , Zhang, Nan , Couch, Fergus J. , Klein, Eric A.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 536-536

10.1200/jco.2018.36.15_suppl.536 Get It

Selection for Oncotype Dx testing among young women with early-stage ER+/HER2- breast cancer.
Poorvu, Philip D. , Gelber, Shari , Rosenberg, Shoshana M. , Ruddy, Kathryn J. , Peppercorn, Jeffrey , Schapira, Lidia , Come, Steven E. , Collins, Laura C. , Tamimi, Rulla M. , Borges, Virginia F. , Warner, Ellen , Partridge, Ann H.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 533-533

10.1200/jco.2018.36.15_suppl.533 Get It